A marked increase in bone mineral density in a patient with glucocorticoid-induced osteoporosis.
During the densitometric follow-up of a 73-yr-old male suffering from bullous pemphigoid and glucocorticoid-induced osteoporosis, a marked increase in bone mineral density (BMD) led to the diagnosis of an asymptomatic prostatic cancer with secondary diffuse bone lesions. This eventuality must be considered in patients with a rapid and unexplained gain in BMD.
Audran
M
M
Department of Rheumatology, CHU and Faculty of Medicine, Angers, France. MaAudran@chu-angers.fr
Audran-Avenel
M
M
Simon
Y
Y
Legrand
E
E
D015502:Absorptiometry, Photon; D000368:Aged; D015519:Bone Density; D001859:Bone Neoplasms / Q000175:diagnosis / Q000556:secondary*; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000139:chemically induced* / Q000473:pathology; D011241:Prednisone / Q000009:adverse effects*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000473:pathology
D005938:Glucocorticoids; D011241:Prednisone